The FDA approved revakinagene taroretcel (Encelto) as the first treatment for adults with idiopathic macular telangiectasia ...

The Food and Drug Administration (FDA) has approved Encelto (revakinagene taroretcel-lwey) for the treatment of macular telangiectasia type 2 (MacTel).

The FDA has approved Susvimo (ranibizumab injection) for the treatment of patients with diabetic macular edema.

ENCELTO is the First and Only FDA-approved Treatment for MacTel. CUMBERLAND, RI, USA I March 06, 2025 I Neurotech Pharmaceuticals, Inc., a private biotech company focused on d ...

More than 50,000 people over State Pension age are also claiming Attendance Allowance - a tax-free benefit, claimed by more ...

The most common adverse reactions reported with Susvimo were conjunctival hemorrhage, conjunctival hyperemia, iritis, eye pain, cataract, conjunctival disorder, and vitreous hemorrhage.

A six-year-old girl died of internal bleeding following a medical procedure at a Cambridge hospital. Amelia Ridout underwent a bilateral bone marrow aspirate and trephine procedure at Addenbrooke ...

The most common adverse reactions reported with avacincaptad pegol were conjunctival hemorrhage, increased intraocular pressure, blurred vision, and neovascular AMD. The 24- month analysis showed ...

A bleeding Rachin Ravindra left the pitch after being hit near his eye by the ball during the first one-day international between New Zealand and Pakistan at the Gaddafi Stadium in Lahore on Saturday.